CD276 and ovarian cancer: The B7 homolog 3 (CD276 or B7-H3), a member of the B7 immune checkpoint family is rather specifically expressed in many human cancers, including glioma, ovarian cancer, neuroblastoma, lung adenocarcinoma, pancreatic cancer, certain sarcomas, and AML.